Melisa M. Saye

Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

The potential of the antifungal nystatin to be repurposed to fight the protozoan Trypanosoma cruzi.

The potential of the antifungal nystatin to be repurposed to fight the protozoan Trypanosoma cruzi.

Journal: Frontiers in microbiology

Published: December 04, 2024

Identifying inhibitors of Trypanosoma cruzi nucleoside diphosphate kinase 1 as potential repurposed drugs for Chagas' disease.

Identifying inhibitors of Trypanosoma cruzi nucleoside diphosphate kinase 1 as potential repurposed drugs for Chagas' disease.

Journal: Biochemical pharmacology

Published: May 30, 2023

Synthetic Activity of Recombinant Whole Cell Biocatalysts Containing 2-Deoxy-D-ribose-5-phosphate Aldolase from Pectobacterium atrosepticum.

Synthetic Activity of Recombinant Whole Cell Biocatalysts Containing 2-Deoxy-D-ribose-5-phosphate Aldolase from Pectobacterium atrosepticum.

Journal: Chembiochem : a European journal of chemical biology

Published: March 14, 2022

Revisiting trypanosomatid nucleoside diphosphate kinases.

Revisiting trypanosomatid nucleoside diphosphate kinases.

Journal: Memorias do Instituto Oswaldo Cruz

Published: October 18, 2021

Trypanocidal activity of the anthocyanidin delphinidin, a non-competitive inhibitor of arginine kinase.

Trypanocidal activity of the anthocyanidin delphinidin, a non-competitive inhibitor of arginine kinase.

Journal: Natural product research

Published: July 05, 2021

Effect of capsaicin on the protozoan parasite Trypanosoma cruzi.

Effect of capsaicin on the protozoan parasite Trypanosoma cruzi.

Journal: FEMS microbiology letters

Published: June 29, 2020

Expanding the scope of synthetic 1,2,4-trioxanes towards Trypanosoma cruzi and Leishmania donovani.

Expanding the scope of synthetic 1,2,4-trioxanes towards Trypanosoma cruzi and Leishmania donovani.

Journal: Bioorganic & medicinal chemistry letters

Published: May 28, 2020

Computational approaches for drug discovery against trypanosomatid-caused diseases.

Computational approaches for drug discovery against trypanosomatid-caused diseases.

Journal: Parasitology

Published: February 13, 2020

Role of Trypanosoma cruzi nucleoside diphosphate kinase 1 in DNA damage responses.

Role of Trypanosoma cruzi nucleoside diphosphate kinase 1 in DNA damage responses.

Journal: Memorias do Instituto Oswaldo Cruz

Published: January 15, 2020

Chagas Disease Treatment: From New Therapeutic Targets to Drug Discovery and Repositioning.

Chagas Disease Treatment: From New Therapeutic Targets to Drug Discovery and Repositioning.

Journal: Current medicinal chemistry

Published: December 19, 2019

In silico repositioning of etidronate as a potential inhibitor of the Trypanosoma cruzi enolase.

In silico repositioning of etidronate as a potential inhibitor of the Trypanosoma cruzi enolase.

Journal: Journal of molecular graphics & modelling

Published: July 31, 2019

Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.

Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.

Journal: PLoS neglected tropical diseases

Published: May 16, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026